Increased levels of CgA have been immunologically detected in the blood of patients with neuroendocrine tumors or with tumors that undergo neuroendocrine differentiation, including prostate, breast and non-small cell lung cancer [2, 6-8]. The gene discussed is CGA; the disease is non-small cell lung carcinoma.